{
  "id": "SCR-LIP-000588",
  "statement": "Lipedema prevalence estimates vary widely and remain uncertain, partly because of underdiagnosis and the lack of validated diagnostic criteria.",
  "claim_type": "clinical_association",
  "context": {
    "population": "women with lower limb lipedema (n=191)",
    "condition": "lipedema",
    "exposure": "ultrasound-assisted liposuction",
    "comparator": "pre-operative baseline",
    "outcome": "surgical outcomes post-liposuction",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "very_low",
  "evidence": [
    {
      "ref": "DOI:10.1002/oby.22597",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2019,
      "amato_authored": false,
      "note": "This narrative review explicitly states that lipedema is underdiagnosed and misdiagnosed, and calls for increased awareness and better understanding of its clinical presentation to improve diagnosis, directly supporting the affirmative dire",
      "title": "Lipedema: A Call to Action!",
      "authors": "Buso et al.",
      "journal": "Obesity",
      "grade": "very_low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": false,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "Human review: statement rewritten — removed an erroneous '191-cohort / UAL surgical outcomes' framing that belonged to a different study; kept the epidemiology (~11%, often misdiagnosed) supported by these reviews.",
        "date": "2026-06-10",
        "reviewed_by": "Amato (ORCID 0000-0003-4008-4029)",
        "reviewed_date": "2026-06-12"
      },
      "quote": "Prevalência mínima: 1:72.000 na população geral (Child et al.), considerado subestimação — estudo alemão com 62 mulheres profissionais detectou lipedema em 39% (todos os estágios), 9,7% para apresentação moderada a grave",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Review cites a minimum prevalence of 1:72,000 in the general population, considered an underestimate, versus 39% (9.7% moderate-severe) in a German sample of 62 professional women.",
      "from_claims": [
        "SCR-LIP-000063"
      ]
    },
    {
      "ref": "DOI:10.1111/obr.13953",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2025,
      "amato_authored": false,
      "note": "This systematic review directly addresses underrecognition and diagnostic challenges in lipedema, supporting the affirmative direction of the question, though it does not specifically evaluate screening tools.",
      "title": "Lipedema: Progress, Challenges, and the Road Ahead",
      "authors": "Cifarelli",
      "journal": "Obesity Reviews",
      "grade": "very_low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": false,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "Human review: statement rewritten — removed an erroneous '191-cohort / UAL surgical outcomes' framing that belonged to a different study; kept the epidemiology (~11%, often misdiagnosed) supported by these reviews.",
        "date": "2026-06-10",
        "reviewed_by": "Amato (ORCID 0000-0003-4008-4029)",
        "reviewed_date": "2026-06-12"
      },
      "quote": "Prevalência estimada de 6–11% em mulheres na população geral; prevalência mundial ~10% — subestimada por ausência de código ICD-10 nos EUA e falta de biomarcador diagnóstico validado",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Review gives estimated prevalence of 6-11% in women (worldwide about 10%), considered underestimated due to absent ICD-10 code in the US and no validated diagnostic biomarker.",
      "from_claims": [
        "SCR-LIP-000063"
      ]
    },
    {
      "ref": "DOI:10.3390/jpm13010098",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2022,
      "amato_authored": false,
      "note": "This narrative review provides contextual background on lipedema's history, affected population (women), and clinical characteristics, but does not report specific prevalence or incidence data, making it contextually relevant but not direct",
      "title": "Lipedema Research—Quo Vadis?",
      "authors": "Ernst et al.",
      "journal": "Journal of Personalized Medicine",
      "grade": "very_low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article provides background context on lipedema as a serious disease affecting women, first described by Allen and Hines in 1940, and notes limitations in prevalence/incidence data. The statement's claim of 'undetermined genetic backgro",
        "date": "2026-06-10"
      },
      "quote": "Prevalência mundial estimada em 11% entre mulheres — dado ampliado por subdiagnóstico, mas com limitação diagnóstica reconhecida pelos autores Incidência familiar em 15% de familiares femininas de primeiro grau",
      "extraction_confidence": "high",
      "stance_in_source_claim": "context",
      "finding": "Review cites an estimated 11% worldwide prevalence in women with acknowledged diagnostic limitation, and states true prevalence and incidence remain poorly defined.",
      "from_claims": [
        "SCR-LIP-000078"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000063",
    "SCR-LIP-000078"
  ],
  "questions_consolidated": [
    "SQ-LIP-000002"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00080",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000002"
    }
  ],
  "statement_pt": "As estimativas de prevalência do lipedema variam amplamente e permanecem incertas, em parte pelo subdiagnóstico e pela ausência de critérios diagnósticos validados.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000002",
      "role": "refines",
      "question": "How common is lipedema, and who does it affect?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000002.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000588.html"
}